Leptin induces neuroprotection neurogenesis and angiogenesis after stroke

• Published in: Current neurovascular research Vol. 8; no. 4; p. 313
• Main Authors: Avraham, Y, Davidi, N, Lassri, V, Vorobiev, L, Kabesa, M, Dayan, M, Chernoguz, D, Berry, E, Leker, R R
• Format: Journal Article
• Language: English
• Published: United Arab Emirates 01.11.2011
• Subjects: Animals; Blood Vessels - drug effects; Blood Vessels - pathology; Brain Infarction - etiology; Brain Infarction - prevention & control; Bromodeoxyuridine - metabolism; CD3 Complex - metabolism; Cell Count; Cell Differentiation - drug effects; Cells, Cultured; Disability Evaluation; Disease Models, Animal; Dose-Response Relationship, Drug; Embryo, Mammalian; Fibroblast Growth Factors - pharmacology; Glial Fibrillary Acidic Protein - metabolism; Leptin - pharmacology; Leptin - therapeutic use; Mice; Neovascularization, Pathologic - etiology; Neovascularization, Pathologic - prevention & control; Neural Stem Cells - drug effects; Neurogenesis - drug effects; Neuroprotective Agents - pharmacology; Neuroprotective Agents - therapeutic use; Protein Kinases - metabolism; Receptors, Leptin - genetics; Receptors, Leptin - metabolism; Stroke - complications; Time Factors; TRPV Cation Channels - genetics; TRPV Cation Channels - metabolism; Tubulin - metabolism
• ISSN: 1875-5739
• DOI: 10.2174/156720211798120954

Leptin is a potent AMP kinase (AMPK) inhibitor that is central to cell survival. Hence, we explored the effects of leptin on neurogenesis and angiogenesis after stroke. Neural stem cells (NSC) were grown as neurospheres in culture and treated with vehicle or leptin and neurosphere size and terminal differentiation were then determined. We then explored the effects of leptin on endogenous repair mechanisms in vivo. Sabra mice underwent photothrombotic stroke, were given vehicle or leptin and newborn cells were labeled with Bromo-deoxy-Uridine. Functional outcome was studied with the neurological severity score for 90 days post stroke and the brains were then evaluated with immunohistochemistry. In a subset of animals the brains were also evaluated for changes in the expression of leptin receptor and AMPK. In vitro, leptin led to a 2-fold increase in neurosphere size but did not change the differentiation of newborn cells. Following stroke, exogenous leptin led to a 4-fold increase in the number of NSC in the cortex abutting the lesion. There was a 1.5-fold increase in the number of newborn neurons and glia in leptin treated animals. Leptin also significantly increased the number of blood vessels in the peri-lesioned cortex. Leptin treated mice had increased expression of leptin receptor and increased phosphorylated AMPK concentration. Animals treated with leptin also had significantly better functional states. In conclusion, leptin induces neurogenesis and angiogenesis after stroke and leads to increased leptin receptor and pAMPK concentrations. This may explain at least in part the better functional outcome observed in leptin treated animals after stroke.